<DOC>
	<DOCNO>NCT02707211</DOCNO>
	<brief_summary>To test whether active pneumococcus immunization alleviate inflammation improve cholesterol metabolism lysosomal lipid storage disease associate metabolic disorder .</brief_summary>
	<brief_title>Anti-oxLDL IgM Antibodies Novel Therapy Metabolic Lipid Diseases</brief_title>
	<detailed_description>Growing evidence describes central role oxidize low density lipoprotein ( oxLDL ) diseases related lipid metabolism . Moreover , oxLDL show involved pathological process inappropriate inflammatory response , disturbance cholesterol metabolism dysfunction lysosomal apparatus . Relevantly , show immunize mouse Streptococcus pneumoniae result higher serum titer anti-oxLDL IgM antibody due molecular mimicry .</detailed_description>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Patients follow disease ( characterize lysosomal lipid storage associate metabolic pathology ) Familial hypercholesterolemia , NPB , NPC Partial lipodystrophy ( PPARg mutation laminin A/C mutation ) Intention treat participate treatment Written inform consent Medical condition may interfere study procedure : cancer Hodgkin lymphoma ( relate immune cell ) ; autoimmune disease ; immune deficiency ; splenectomy syndrome Alcohol abuse ( quantitative limit &gt; 20g/day men &gt; 10g woman ) Illiteracy Patients young 10 year . Any condition opinion ( co ) investigator might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>